Shares of Myos Rens Technology Inc. more than doubled on heavy volume Friday on no apparent news, for the second time in less than a month. The stock rocketed 112% in afternoon trade, enough to make it the biggest gainer on the Nasdaq exchange. Volume spiked to 19.3 million shares, which was about 21 times the full-day average. The company did not release any news Friday, a company spokesperson told MarketWatch. Myos Rens is a biotherapeutics and bionutrition company, which says on its website that its Fortetropin product is a “clinically proven natural” way to build lean muscle. On Jan. 11, the stock soared more than five fold–from $1.30 to $6.82–on volume of 16.4 million shares, also as the company did not release any news. The stock has now run up nearly four-fold over the past 12 months, while the iShares Nasdaq Biotechnology ETF has tacked on 7% and the S&P 500 has gained 20%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News